These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Single tyrosine mutation in AAV8 and AAV9 capsids is insufficient to enhance gene delivery to skeletal muscle and heart. Qiao C; Yuan Z; Li J; Tang R; Li J; Xiao X Hum Gene Ther Methods; 2012 Feb; 23(1):29-37. PubMed ID: 22428978 [TBL] [Abstract][Full Text] [Related]
3. Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo. Song L; Kauss MA; Kopin E; Chandra M; Ul-Hasan T; Miller E; Jayandharan GR; Rivers AE; Aslanidi GV; Ling C; Li B; Ma W; Li X; Andino LM; Zhong L; Tarantal AF; Yoder MC; Wong KK; Tan M; Chatterjee S; Srivastava A Cytotherapy; 2013 Aug; 15(8):986-98. PubMed ID: 23830234 [TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. Halbert CL; Allen JM; Miller AD J Virol; 2001 Jul; 75(14):6615-24. PubMed ID: 11413329 [TBL] [Abstract][Full Text] [Related]
5. High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivo. Song L; Li X; Jayandharan GR; Wang Y; Aslanidi GV; Ling C; Zhong L; Gao G; Yoder MC; Ling C; Tan M; Srivastava A PLoS One; 2013; 8(3):e58757. PubMed ID: 23516552 [TBL] [Abstract][Full Text] [Related]
6. Quantifying transduction efficiencies of unmodified and tyrosine capsid mutant AAV vectors in vitro using two ocular cell lines. Ryals RC; Boye SL; Dinculescu A; Hauswirth WW; Boye SE Mol Vis; 2011 Apr; 17():1090-102. PubMed ID: 21552473 [TBL] [Abstract][Full Text] [Related]
7. Tyrosine Mutation in AAV9 Capsid Improves Gene Transfer to the Mouse Lung. Martini SV; Silva AL; Ferreira D; Rabelo R; Ornellas FM; Gomes K; Rocco PR; Petrs-Silva H; Morales MM Cell Physiol Biochem; 2016; 39(2):544-53. PubMed ID: 27384068 [TBL] [Abstract][Full Text] [Related]
8. Efficient Gene Delivery and Expression in Pancreas and Pancreatic Tumors by Capsid-Optimized AAV8 Vectors. Chen M; Maeng K; Nawab A; Francois RA; Bray JK; Reinhard MK; Boye SL; Hauswirth WW; Kaye FJ; Aslanidi G; Srivastava A; Zajac-Kaye M Hum Gene Ther Methods; 2017 Feb; 28(1):49-59. PubMed ID: 28125909 [TBL] [Abstract][Full Text] [Related]
9. A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection. Yang L; Jiang J; Drouin LM; Agbandje-McKenna M; Chen C; Qiao C; Pu D; Hu X; Wang DZ; Li J; Xiao X Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3946-51. PubMed ID: 19234115 [TBL] [Abstract][Full Text] [Related]
10. High-Efficiency Transduction of Primary Human Hematopoietic Stem/Progenitor Cells by AAV6 Vectors: Strategies for Overcoming Donor-Variation and Implications in Genome Editing. Ling C; Bhukhai K; Yin Z; Tan M; Yoder MC; Leboulch P; Payen E; Srivastava A Sci Rep; 2016 Oct; 6():35495. PubMed ID: 27759036 [TBL] [Abstract][Full Text] [Related]
11. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. Halbert CL; Rutledge EA; Allen JM; Russell DW; Miller AD J Virol; 2000 Feb; 74(3):1524-32. PubMed ID: 10627564 [TBL] [Abstract][Full Text] [Related]
12. Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells. Sayroo R; Nolasco D; Yin Z; Colon-Cortes Y; Pandya M; Ling C; Aslanidi G Gene Ther; 2016 Jan; 23(1):18-25. PubMed ID: 26270885 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the impact of pluronic acid on the thermal stability and infectivity of AAV6.2FF. Thomas SP; Spinelli MM; Rghei AD; Lopes JA; Zielinska N; McLeod BM; Pei Y; Zhang W; Thebaud B; Karimi K; Wootton SK BMC Biotechnol; 2024 Apr; 24(1):22. PubMed ID: 38664752 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site. Huang LY; Patel A; Ng R; Miller EB; Halder S; McKenna R; Asokan A; Agbandje-McKenna M J Virol; 2016 Jun; 90(11):5219-5230. PubMed ID: 26962225 [TBL] [Abstract][Full Text] [Related]
15. Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of Cancer. Pandya M; Britt K; Hoffman B; Ling C; Aslanidi GV J Immunother; 2015 Sep; 38(7):292-8. PubMed ID: 26261893 [TBL] [Abstract][Full Text] [Related]
16. Transduction Efficiency of Adeno-Associated Virus Serotypes After Local Injection in Mouse and Human Skeletal Muscle. Muraine L; Bensalah M; Dhiab J; Cordova G; Arandel L; Marhic A; Chapart M; Vasseur S; Benkhelifa-Ziyyat S; Bigot A; Butler-Browne G; Mouly V; Negroni E; Trollet C Hum Gene Ther; 2020 Feb; 31(3-4):233-240. PubMed ID: 31880951 [TBL] [Abstract][Full Text] [Related]
17. Ocular Inflammatory Response to Intravitreal Injection of Adeno-Associated Virus Vector: Relative Contribution of Genome and Capsid. Timmers AM; Newmark JA; Turunen HT; Farivar T; Liu J; Song C; Ye GJ; Pennock S; Gaskin C; Knop DR; Shearman MS Hum Gene Ther; 2020 Jan; 31(1-2):80-89. PubMed ID: 31544533 [TBL] [Abstract][Full Text] [Related]
18. An adeno-associated virus vector efficiently and specifically transduces mouse skeletal muscle. Murakami I; Takeuchi T; Mori-Uchino M; Mori S; Fujii T; Aoki D; Nakagawa K; Kanda T Mol Biotechnol; 2011 Sep; 49(1):1-10. PubMed ID: 21197588 [TBL] [Abstract][Full Text] [Related]
19. Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice. Rivière C; Danos O; Douar AM Gene Ther; 2006 Sep; 13(17):1300-8. PubMed ID: 16688207 [TBL] [Abstract][Full Text] [Related]
20. Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes. Wu Z; Asokan A; Grieger JC; Govindasamy L; Agbandje-McKenna M; Samulski RJ J Virol; 2006 Nov; 80(22):11393-7. PubMed ID: 16943302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]